Franklin Resources INC Schedule 13G passive stakes

Franklin Resources, Inc. and its subsidiaries have disclosed a 7.2% beneficial ownership stake in Infinity Natural Resources, Inc.'s Class A common stock.

Franklin Resources, Inc. reports a 3.9% beneficial ownership stake in Eastman Chemical Company common stock in an amended Schedule 13G filing.

Franklin Resources, Inc. has filed an amended Schedule 13G, disclosing a reduced beneficial ownership of 4.3% in Guardian Pharmacy Services, Inc.

Franklin Resources, Inc. and its subsidiary Franklin Advisers, Inc. have disclosed an 8.9% beneficial ownership stake in Contineum Therapeutics, Inc.

Franklin Resources, Inc. and its affiliates have reported an 8.0% beneficial ownership stake in Albemarle Corporation, primarily for passive investment purposes.

Franklin Resources, Inc. and its subsidiary Franklin Advisers, Inc. have filed an amendment to their beneficial ownership of 16.0% in Achieve Life Sciences, Inc., including shares issuable from warrants.

Franklin Resources, Inc. and its principal shareholders report 0% beneficial ownership in 4Front Ventures Corp. Class A Subordinate Voting Shares.

Franklin Resources, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 4,000 Class I Shares, representing 0.02% of Franklin Lexington Private Markets Fund.

Franklin Resources, Inc. has filed an amended Schedule 13G, disclosing a 1.0% beneficial ownership stake in Vontier Corporation as of March 31, 2025.

Franklin Resources, Inc. has filed an amendment to its Schedule 13G, reporting a reduced beneficial ownership of 4.7% in Vizsla Silver Corp., down from a previous stake above 5%.

Franklin Resources, Inc. and its affiliates have filed a Schedule 13G, reporting beneficial ownership of 5.4% of Infinity Natural Resources, Inc.'s Class A common stock as of March 31, 2025.

Franklin Resources, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 8.0% of Guardian Pharmacy Services, Inc.'s Class A Common Stock as of March 31, 2025.

Franklin Resources, Inc. and its affiliates have reported a 5.1% beneficial ownership stake in Eastman Chemical Company, held for investment purposes in the ordinary course of business.

Franklin Resources, Inc. has filed an amended Schedule 13G indicating its beneficial ownership in CONTEXT THERAPEUTICS INC. has decreased to 4.5% of the common stock.

Franklin Resources, Inc. and its affiliates, including Franklin Advisers, Inc., have disclosed a beneficial ownership of 16.3% in Benitec Biopharma Inc., totaling 4,415,130 shares as of March 31, 2025.

Franklin Resources, Inc. and its affiliates have filed a Schedule 13G, reporting a combined beneficial ownership of 7.0% in Albemarle Corporation's common stock as of March 31, 2025.

Franklin Resources, Inc. and its subsidiary Franklin Advisers, Inc. have disclosed a beneficial ownership of 12.6% of Achieve Life Sciences, Inc.'s common stock, including shares issuable from warrants.

Franklin Resources, Inc. and its subsidiary Putnam Investment Management, LLC have disclosed a passive beneficial ownership of 6.7% in 4Front Ventures Corp.'s Class A Subordinate Voting Shares.

Franklin Resources, Inc. has filed a Schedule 13G, reporting a passive beneficial ownership of 1.0% in Assured Guaranty Ltd. as of September 30, 2024, following its acquisition of Putnam Investments LLC.

Franklin Resources, Inc. and its principals, Charles B. Johnson and Rupert H. Johnson, Jr., have filed an amended Schedule 13G indicating they no longer beneficially own any shares of Marinus Pharmaceuticals, Inc. common stock as of December 31, 2024.

Franklin Resources, Inc. and its investment adviser subsidiary, Franklin Advisers, Inc., have disclosed a beneficial ownership of 5.7% in Vizsla Silver Corp., totaling 16,117,500 common shares, as of December 31, 2024.

Franklin Resources, Inc. and its affiliates have filed an amended Schedule 13G, disclosing a beneficial ownership of 6.9% of Paymentus Holdings, Inc.'s Class A Common Stock as of December 31, 2024.

Franklin Resources, Inc. and its subsidiary Franklin Advisers, Inc. have filed an amended Schedule 13G, confirming their beneficial ownership of 7.4% of Integra Resources Corp.'s common shares as of December 31, 2024.

Investment giant Franklin Resources, Inc. has filed an amended Schedule 13G, disclosing its beneficial ownership of 7.1% of Innoviva, Inc.'s common stock as of December 31, 2024.

Franklin Resources, Inc. and its affiliates have filed an amendment to their Schedule 13G, disclosing a continued passive beneficial ownership of 6.1% in EyePoint Pharmaceuticals, Inc. as of December 31, 2024.

Franklin Resources, Inc. and its subsidiary Franklin Advisers, Inc. have disclosed a 5.3% beneficial ownership stake in CONTEXT THERAPEUTICS INC. as of December 31, 2024.

Franklin Resources, Inc. and its subsidiary Franklin Advisers, Inc. have reported a combined beneficial ownership of 18.1% of Benitec Biopharma Inc.'s common stock, including shares from warrant exercises.

Franklin Resources, Inc. has filed an amended Schedule 13G, reporting a 1.7% beneficial ownership stake in Applied Therapeutics, Inc. as of December 31, 2024.